drugset / Trial / NCT00645164

Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment

NCT00645164 ↗

Phase 1 Completed 59 enrolled Healthpoint
NaSingle-groupQuadruple-blind

Summary

The product is being tested to see if exposure to light causes photoallergic reactions on the skin.

Timeline

Start
2008-03
Primary completion
2008-05
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Xenaderm Unknown 20 mg Topical

Indications

No indication recorded.